About Teradyne
Teradyne (NYSE: TER) is a leading supplier of Automatic Test Equipment used to test semiconductors, wireless products, data storage and complex electronic systems which serve consumer, communications, industrial and government customers. In 2014, Teradyne had revenue of $1.65 billion and currently employs approximately 3,900 people worldwide. For more information, visit www.teradyne.com. Teradyne (R) is a registered trademark of Teradyne, Inc. in the U.S. and other countries.
Safe Harbor Statement
This release contains forward-looking statements regarding future business prospects, Teradyne’s results of operations, market conditions, the payment of a quarterly dividend and the repurchase of Teradyne common stock pursuant to a share repurchase program. Such statements are based on the current assumptions and expectations of Teradyne’s management and are neither promises nor guarantees of future performance, future payment of dividends or future repurchases of common stock. You can identify these forward-looking statements based on the context of the statements and by the fact that they use words such as “will,” “anticipate,” “expect,” “project,” “intend,” “plan,” “believe,” “target” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. There can be no assurance that management’s estimates of Teradyne’s future results or other forward looking statements will be achieved or that dividends will be declared in the future. Additionally, the share repurchase program may be suspended or discontinued at any time. Important factors that could cause actual results, dividend payments, or repurchases of common stock to differ materially from those presently expected include: conditions affecting the markets in which Teradyne operates; decreased or delayed product demand; increased research and development spending; deterioration of Teradyne’s financial condition, the business judgment of the board of directors that a declaration of a dividend or the repurchase of common stock is not in the company’s best interests and other events, factors and risks disclosed in filings with the SEC, including, but not limited to, the “Risk Factors” section of Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013 and Quarterly Report on Form 10-Q for the period ended September 28, 2014. The forward-looking statements provided by Teradyne in this press release represent management’s views as of the date of this release. Teradyne anticipates that subsequent events and developments may cause management's views to change. However, while Teradyne may elect to update these forward-looking statements at some point in the future, Teradyne specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Teradyne's views as of any date subsequent to the date of this release.
TERADYNE, INC. REPORT FOR FOURTH FISCAL QUARTER OF 2014 | |||||||||||||||||||||||||
CONDENSED CONSOLIDATED OPERATING STATEMENTS | |||||||||||||||||||||||||
(In thousands, except per share amounts) | |||||||||||||||||||||||||
Quarter Ended | Twelve Months Ended | ||||||||||||||||||||||||
December 31, 2014 | September 28, 2014 | December 31, 2013 | December 31, 2014 | December 31, 2013 | |||||||||||||||||||||
Net revenues | $ | 323,236 | $ | 478,010 | $ | 285,301 | $ | 1,647,824 | $ | 1,427,933 | |||||||||||||||
Cost of revenues (exclusive of acquired intangible assets amortization shown separately below) (1) (2) | 163,010 | 216,889 | 125,444 | 769,016 | 619,132 | ||||||||||||||||||||
Gross profit | 160,226 | 261,121 | 159,857 | 878,808 | 808,801 | ||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||
Engineering and development (1) | 79,188 | 71,953 | 64,613 | 291,639 | 264,055 | ||||||||||||||||||||
Selling and administrative (1) (3) | 91,157 | 73,064 | 69,523 | 319,713 | 279,560 | ||||||||||||||||||||
Acquired intangible asset amortization | 15,957 | 18,271 | 18,284 | 70,771 | 72,447 | ||||||||||||||||||||
Goodwill impairment | 98,897 | - | - | 98,897 | - | ||||||||||||||||||||
Restructuring and other (4) | 1,198 | (405 | ) | 600 | 1,365 | 2,080 | |||||||||||||||||||
Operating expenses | 286,397 | 162,883 | 153,020 | 782,385 | 618,142 | ||||||||||||||||||||
(Loss) income from operations | (126,171 | ) | 98,238 | 6,837 | 96,423 | 190,659 | |||||||||||||||||||
Interest and other (5) | 1,358 | 2,432 | 28,602 | (1,047 | ) | 11,263 | |||||||||||||||||||
(Loss) income before income taxes | (124,813 | ) | 100,670 | 35,439 | 95,376 | 201,922 | |||||||||||||||||||
Income tax (benefit) provision | (21,002 | ) | 17,721 | 13,096 | 14,104 | 36,975 | |||||||||||||||||||
Net (loss) income | $ | (103,811 | ) | $ | 82,949 | $ | 22,343 | $ | 81,272 | $ | 164,947 | ||||||||||||||
Net (loss) income per common share: |
|||||||||||||||||||||||||
Basic | $ | (0.48 | ) | $ | 0.40 | $ | 0.12 | $ | 0.40 | $ | 0.86 | ||||||||||||||
Diluted | $ | (0.48 | ) | $ | 0.38 | $ | 0.09 | $ | 0.37 | $ | 0.70 | ||||||||||||||
Weighted average common shares - basic | 216,532 | 207,381 | 191,525 | 202,908 | 190,772 | ||||||||||||||||||||
Weighted average common shares - diluted (6) | 216,532 | 218,333 | 236,903 | 222,550 | 235,599 | ||||||||||||||||||||
Cash dividend declared per common share | $ | 0.06 | $ | 0.06 | $ | - | $ | 0.18 | $ | - | |||||||||||||||
Net orders | $ | 331,993 | $ | 273,043 | $ | 289,653 | $ | 1,681,950 | $ | 1,434,145 | |||||||||||||||
(1) | In the first quarter of 2012, we changed our accounting method from delayed recognition of actuarial gains and losses for our defined benefit pension plans and other post retirement benefit plans to immediate recognition. We elected to immediately recognize net actuarial gains and losses and the change in the fair value of plan assets in our operating results in the year in which they occur. Below are the pension losses (gains) included in our operating results: | ||||||||||||||||||||||||
Quarter Ended | Twelve Months Ended | ||||||||||||||||||||||||
December 31, 2014 | September 28, 2014 | December 31, 2013 | December 31, 2014 | December 31, 2013 | |||||||||||||||||||||
Cost of revenues | $ | 12,713 | $ | - | $ | (2,717 | ) | $ | 12,713 | $ | (3,052 | ) | |||||||||||||
Engineering and development | 12,223 | - | (3,747 | ) | 12,223 | (4,406 | ) | ||||||||||||||||||
Selling and administrative | 21,628 | - | (2,517 | ) | 21,628 | (2,882 | ) | ||||||||||||||||||
$ | 46,564 | $ | - | $ | (8,981 | ) | $ | 46,564 | $ | (10,340 | ) | ||||||||||||||
(2) | Cost of revenues includes: | Quarter Ended | Twelve Months Ended | ||||||||||||||||||||||
December 31, 2014 | September 28, 2014 | December 31, 2013 | December 31, 2014 | December 31, 2013 | |||||||||||||||||||||
Provision for excess and obsolete inventory | $ | 688 | $ | 6,434 | $ | 6,976 | $ | 22,193 | $ | 16,592 | |||||||||||||||
Sale of previously written down inventory | (3,332 | ) | (6,332 | ) | (861 | ) | (13,058 | ) | (9,795 | ) | |||||||||||||||
$ | (2,644 | ) | $ | 102 | $ | 6,115 | $ | 9,135 | $ | 6,797 | |||||||||||||||
(3) | For the twelve months ended December 31, 2014, selling and administrative expenses include an equity charge of $6,598 for the modification of Teradyne's retired CEO's outstanding equity awards to allow continued vesting and maintain the original term in connection with his January 31, 2014 retirement. | ||||||||||||||||||||||||
(4) | Restructuring and other consists of: | Quarter Ended | Twelve Months Ended | ||||||||||||||||||||||
December 31, 2014 | September 28, 2014 | December 31, 2013 | December 31, 2014 | December 31, 2013 | |||||||||||||||||||||
Employee severance | $ | 826 | $ | 225 | $ | 600 | $ | 1,623 | $ | 2,528 | |||||||||||||||
Acquisition costs | 372 | - | - | 372 | - | ||||||||||||||||||||
Contingent consideration fair value adjustment | - | (630 | ) | - | (630 | ) | - | ||||||||||||||||||
Facility related | - | - | - | - | (448 | ) | |||||||||||||||||||
$ | 1,198 | $ | (405 | ) | $ | 600 | $ | 1,365 | $ | 2,080 | |||||||||||||||
(5) | Interest and other includes: | Quarter Ended | Twelve Months Ended | ||||||||||||||||||||||
December 31, 2014 | September 28, 2014 | December 31, 2013 | December 31, 2014 | December 31, 2013 | |||||||||||||||||||||
Non-cash convertible debt interest expense | $ | - | $ | - | $ | 4,158 | $ | 4,290 | $ | 15,814 | |||||||||||||||
Gain from sale of an equity investment | - | - | (34,212 | ) | - | (34,212 | ) | ||||||||||||||||||
$ | - | $ | - | $ | (30,054 | ) | $ | 4,290 | $ | (18,398 | ) | ||||||||||||||
(6) | Under GAAP, when calculating diluted earnings per share, convertible debt must be assumed to have converted if the effect on EPS would be dilutive. Diluted shares assume the conversion of the convertible debt as the effect would be dilutive. Accordingly, for the quarter ended December 31, 2013, and for the twelve months ended December 31, 2014 and December 31, 2013, 23.5 million, 5.0 million and 23.3 million shares, respectively, have been included in diluted shares. | ||||||||||||||||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) | |||||||||||
December 31, 2014 | December 31, 2013 (1) | ||||||||||
(unaudited) | |||||||||||
Assets | |||||||||||
Cash and cash equivalents | $ | 294,256 | $ | 341,638 | |||||||
Marketable securities | 533,787 | 586,882 | |||||||||
Accounts receivable | 151,034 | 157,642 | |||||||||
Inventories | 105,129 | 137,939 | |||||||||
Deferred tax assets | 57,239 | 72,478 | |||||||||
Prepayments | 95,819 | 136,374 | |||||||||
Other current assets | 6,582 | 7,324 | |||||||||
Total current assets | 1,243,846 | 1,440,277 | |||||||||
Net property, plant and equipment | 329,038 | 275,236 | |||||||||
Marketable securities | 470,789 | 271,078 | |||||||||
Deferred tax assets | 7,494 | 5,217 | |||||||||
Other assets | 10,419 | 14,591 | |||||||||
Retirement plans assets | 12,896 | 9,342 | |||||||||
Intangible assets | 190,600 | 252,291 | |||||||||
Goodwill | 273,438 | 361,792 | |||||||||
Total assets | $ | 2,538,520 | $ | 2,629,824 | |||||||
Liabilities | |||||||||||
Accounts payable | $ | 47,763 | $ | 62,874 | |||||||
Accrued employees' compensation and withholdings | 100,994 | 95,619 | |||||||||
Deferred revenue and customer advances | 71,603 | 55,404 | |||||||||
Other accrued liabilities | 51,997 | 63,712 | |||||||||
Accrued income taxes | 20,049 | 11,360 | |||||||||
Current debt | - | 186,663 | |||||||||
Total current liabilities | 292,406 | 475,632 | |||||||||
Retirement plans liabilities | 108,460 | 91,517 | |||||||||
Long-term deferred revenue and customer advances | 19,929 | 13,756 | |||||||||
Deferred tax liabilities | 23,315 | 40,686 | |||||||||
Long-term other accrued liabilities | 15,430 | 23,139 | |||||||||
Total liabilities | 459,540 | 644,730 | |||||||||
Shareholders' equity | 2,078,980 | 1,985,094 | |||||||||
. | |||||||||||
Total liabilities and shareholders' equity | $ | 2,538,520 | $ | 2,629,824 | |||||||